[ReneSola Ltd Announces Fourth Quarter and Full Year 2014 Results JIASHAN, China, March 4, 2015 Fourth Quarter 2014 Financial and Operating Highlights · Total solar module shipments were 488.4 megawatts (“MW”), exceeding previous guidance and representing an increase of 5.7% from Q3 2014. Total solar wafer and module shipments in Q4 2014 were 744.3 MW, representing an increase of 12.1%] []
[Press Release iKang Announces Two Acquisitions in Tianjin to Continue Its Nationwide Network Expansion BEIJING, March 3, 2015 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq:KANG), today announced that it had completed the acquisitions of Tianjin Hexi Kangmeng Hezhong Clinic Co., Ltd. and Tianjin Hedong District REMAHO Clinic Co., Ltd., which were set up in 2008] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 Peoples Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]
[Press Release iKang Announces Two Acquisitions in Tianjin to Continue Its Nationwide Network Expansion BEIJING, March 3, 2015 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq:KANG), today announced that it had completed the acquisitions of Tianjin Hexi Kangmeng Hezhong Clinic Co., Ltd. and Tianjin Hedong District REMAHO Clinic Co., Ltd., which were set up in 2008] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 Peoples Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]
[CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT Agreement Company Mr. Min Fang Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy due to resignation of Mr. Dai Feng and to have the Director perform the duties of a director and the Director desires to be so appointed] [FOR RELEASE March 4, 2015 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4Q14 Total Sales Up 36.2% to 58.0 Million / FY14 Total Sales Up 19.6% to $243.3 Million -- -- -- 4Q14 Operating Margin Up 470 Basis Points to 34.0% / FY14 Operating Margin Up 300 Basis Points to 45.7% -- -- 4Q14] []
[CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT Agreement Company Mr. Min Fang Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy due to resignation of Mr. Dai Feng and to have the Director perform the duties of a director and the Director desires to be so appointed] [FOR RELEASE March 4, 2015 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4Q14 Total Sales Up 36.2% to 58.0 Million / FY14 Total Sales Up 19.6% to $243.3 Million -- -- -- 4Q14 Operating Margin Up 470 Basis Points to 34.0% / FY14 Operating Margin Up 300 Basis Points to 45.7% -- -- 4Q14] []
[Annual Report on Form 10-K Year Ended December 31, 2014 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 22 Item 1B. Unresolved Staff Comments 44 Item 2. Properties 44 Item 3. Legal Proceedings 45 Item 4. Mine Safety Disclosures 47 PART II Item 5. 48 Item 6. Selected Financial Data 49 Item 7. Management’s Discussion] [23.1 Consent of Independent Registered Public Accounting Firm The Board of Directors China Biologic Products, Inc.: We consent to the incorporation by reference in registration statements (No. 333-171069, 333-182624 and 333-196591) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 4, 2015, with respect to the consolidated] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial and Accounting Officer)]
[HANWHA Q CELLS APPOINTS TWO SENIOR EXECUTIVES AS DIRECTORS DK KIM RETURNS TO BOARD Company Hanwha Q CELLS SEOUL, SOUTH KOREA March 4, 2015 Hanwha Q CELLS Co., Ltd. (the Mr. Seongwoo Nam, chairman and chief executive officer of Hanwha Q CELLS, said, Both Mr. Kim and Dr. Choi bring unique skills to our Board. Mr. Kim] [Hanwha Q CELLS Co., Ltd. Seong Woo Nam Chairman and CEO 6-K 1 d884271d6k.htm FORM 6-K]
[Country Style Cooking Restaurant Chain Reports Unaudited Fourth Quarter and Fiscal Year 2014 Financial Results 4Q14 Revenues up 7.4% YoY to RMB361.3 Million 4Q14 Adjusted Net Income up 31.1% YoY to RMB9.3 Million 4Q14 Adjusted EBITDA up 7.6% YoY to RMB27.6Million Chongqing, China, March 4, 2015 — Country Style Cooking Restaurant Chain Co., Ltd. (NYSE: CCSC) (“Country Style Cooking” “CSC”] []
[HANWHA Q CELLS APPOINTS TWO SENIOR EXECUTIVES AS DIRECTORS DK KIM RETURNS TO BOARD Company Hanwha Q CELLS SEOUL, SOUTH KOREA March 4, 2015 Hanwha Q CELLS Co., Ltd. (the Mr. Seongwoo Nam, chairman and chief executive officer of Hanwha Q CELLS, said, Both Mr. Kim and Dr. Choi bring unique skills to our Board. Mr. Kim] [Hanwha Q CELLS Co., Ltd. Seong Woo Nam Chairman and CEO 6-K 1 d884271d6k.htm FORM 6-K]
